For Pharma
Specializing in clinical research services with a focus on oncology drug development programs.
SCRI Global Services is a division of the Sarah Cannon Research Institute specializing in strategic clinical research services with a focus on Phase I-III oncology drug development programs.
Relationships with the nearly 500 investigators affiliated with the SCRI strategic sites and the sites in the SCRI Oncology Research Consortium, along with investigators at sites outside the SCRI Network allow SCRI Global Services to offer sponsors access to a diverse and varied patient population spanning multiple tumor types and disease stages. These relationships further enhance the depth and bredth of therapeutic expertise of SCRI Global Services enabling it to provide focused, strategic operational support to ensure clinical trials are conducted in a timely manner and reported with high-quality, registration-standard data.
The following services are available as part of an integrated, full service, trial management program. Additionally, a subset of services may be selected.
Clinical Monitoring
|
Safety
|
||
Project Management
|
Medical Writing
|
||
Data Management
|
Quality Assurance
|
||
Data Safety/Monitoring Board
|
Biostatistics
|
Digg
Del.icio.us
Yahoo
Google
Newsvine